Observational studyJournal of general internal medicine2022
Factors Associated with Compliance to the Hospital Price Transparency Final Rule: a National Landscape Study.
Observational study in Journal of general internal medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Testosterone testing in the United States: limited price transparency and significant variability.International journal of impotence research · 2026Article
- Hospital, regional, and policy-level variations in shoulder arthroplasty prices: a Nationwide database study.JSES reviews, reports, and techniques · 2026Article
- Price-Shifting? Spillovers of Medicare Advantage Network Inclusion on Hospital Prices Paid by Commercial Insurers.Health services research · 2025Article
- Anticipated Out-Of-Pocket Costs and Prostate Cancer Management Among Men With Commercial Insurance.Cancer medicine · 2025Article
- Inter- and Intrahospital Price Variation for Common Cardiovascular Admission Diagnoses, Diagnostic Tests, and Therapeutic Procedures.Journal of the American Heart Association · 2025Article
- Tennessee hospital noncompliance with price transparency legislation for 8 common laboratory tests.American journal of clinical pathology · 2024Article
- Market Factors, Not Quality, Influence Reimbursement for Pancreaticoduodenectomy in an Era of Price Transparency.Annals of surgical oncology · 2024Article
- Burn Care Funding in the Era of Price Transparency-Does Verification Signal Bargaining Power?Journal of burn care & research : official publication of the American Burn Association · 2024Article
- Over- and underreporting of prices: most hospitals are not compliant with the Hospital Price Transparency Rule.Health affairs scholar · 2024Article
- Trends in hospital price transparency after implementation of the CMS Final Rule.Health services research · 2024Article
- Trauma Activation Fees Vary Widely Across US Trauma Centers.Health affairs (Project Hope) · 2024Article
- Payer-Negotiated Price Variation and Relationship to Surgical Outcomes for the Most Common Cancers at NCI-Designated Cancer Centers.Annals of surgical oncology · 2024Article
- Hospital Characteristics Associated with Observed Transcatheter Aortic Valve Replacement Prices.medRxiv : the preprint server for health sciences · 2024Article
- The relationship between community social risk factors and regional hospital-reported cash, negotiated, and chargemaster prices for 14 common services.BMC health services research · 2024Article
- Uncovering the interhospital price variations for vasectomies in the United States.International journal of impotence research · 2024Article
- Hirudotherapy Efficacy and Complications in the Management of Microsurgical Breast Reconstruction: A Systematic Review.World journal of plastic surgery · 2024Review
- Mohs Surgery Price Transparency and Variability at Academic Hospitals After the Implementation of the Federal Price Transparency Final Rule.JMIR dermatology · 2023Article
- Healthcare price transparency in North America and Europe.The British journal of radiology · 2023Review
- Assessing Compliance with Hospital Price Transparency over Time.Journal of general internal medicine · 2023Article
- Provision of Hospital Price Information After Increases in Financial Penalties for Failure to Comply With a US Federal Hospital Price Transparency Rule.JAMA network open · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Hospital Price Transparency Final Rule, effective January 1, 2021, requires hospitals to post online a machine-readable file that includes payer-specific negotiated commercial prices for all services. The regulation aims to improve the affordability of hospital care by promoting price competition. However, a low compliance level among hospitals would compromise the operational effectiveness of this regulation. Understanding hospitals' compliance status to the regulation has important implications for its enforcement effort and effectiveness assessment.
objectiveTo analyze nationwide hospitals' compliance status to the Hospital Price Transparency Rule.
designCross-sectional observational study.
participantsA total of 3558 Medicare-certified general acute-care hospitals were examined. MAIN MEASURES: A binary compliance rating was generated by using data collected by Turquoise Health. "Noncompliance" means that no machine-readable file was posted or the posted file contains no commercial negotiated prices. "Compliance" means that a machine-readable file was posted with commercial negotiated prices for at least one insurance plan. KEY
resultsAs of June 1, 2021, 55% of the 3558 Medicare-certified general acute-care hospitals we examined had not posted a machine-readable file containing commercial negotiated prices. Wide variations of compliance existed across states and hospital referral regions. A hospital's compliance status is strongly associated with the average compliance status of peer hospitals in the same market. Hospitals with greater IT preparedness, for-profit hospitals, system-affiliated hospitals, large hospitals, and non-urban hospitals had greater compliance. More concentrated hospital markets had greater average compliance.
conclusionsHospitals take into consideration the behavior of their peers in the same market when making price disclosure decisions. Compliant hospitals are likely to have better IT preparedness, more financial resources and personnel expertise to mitigate the cost required for the implementation of the Price Transparency Rule. The compliance cost, therefore, might be a barrier for some hospitals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.